2620 篇
1079 篇
194460 篇
3293 篇
6313 篇
2230 篇
2777 篇
537 篇
29569 篇
9593 篇
3153 篇
749 篇
2295 篇
1316 篇
449 篇
752 篇
1387 篇
2601 篇
2737 篇
3998 篇
全球视网膜药物市场报告(2025-2029年)
Global Retinal Drugs Market 2025-2029
Retinal drugs are the medications that are used in the treatment of retinal diseases. Anti-vascular endothelial growth factor (VEGF) agents and corticosteroids are the two major drug classes that are being used for the treatment of various retinal diseases such as wet age-related Macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and myopic choroidal neovascularization (mCNV). Among them, anti-VEGF agents are considered the gold standard for the treatment of various retinal diseases such as AMD, DME, and RVO.